/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

SAVARA INC Share Price Today: Live Updates & Key Insights

SAVARA INC share price today is $5.02, up -3.88%. The stock opened at $5.2 against the previous close of $5.16, with an intraday high of $5.2 and low of $4.905.

SAVARA INC Share Price Chart

style
pb-0

SAVARA INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

SAVARA INC Share Price Performance

$5.02 -0.0388(-3.88%) SVRA at 23 Mar 2026 03:23 PM Biotechnology
Lowest Today 4.905
Highest Today 5.2
Today’s Open 5.2
Prev. Close 5.16
52 Week High 7.01
52 Week Low 1.89
Day’s Range: Low 4.905 High 5.2
52-Week Range: Low 1.89 High 7.01
1 day return -
1 Week return -4.96
1 month return -12.93
3 month return -23.02
6 month return +42.69
1 year return +76.59
3 year return +160.73
5 year return +158.03
10 year return -

SAVARA INC Institutional Holdings

NEA Management Company, LLC 12.03

Bain Capital Life Sciences Investors, LLC 8.65

VR Adviser, LLC 6.75

Deerfield Management Co 6.67

TCG Crossover Management, LLC 6.08

Vanguard Group Inc 4.94

Frazier Life Sciences Management, L.P. 4.85

BlackRock Inc 4.15

Polar Capital Holdings PLC 4.08

Polar Capital Healthcare Opports Inc 3.87

Nantahala Capital Management, LLC 3.61

Vanguard Total Stock Mkt Idx Inv 2.98

RTW INVESTMENTS, LLC 2.93

Marshall Wace Asset Management Ltd 2.24

Woodline Partners LP 2.09

Emerald Advisers, LLC 1.72

iShares Russell 2000 ETF 1.71

Geode Capital Management, LLC 1.68

Rosalind Advisors, Inc. 1.67

Affinity Asset Advisors, LLC 1.37

Wellington Management Company LLP 1.31

Spruce Street Capital LP 1.19

Emerald Mutual Fund Advisers Trust 1.18

State Street® SPDR® S&P® Biotech ETF 0.74

Vanguard Institutional Extnd Mkt Idx Tr 0.73

Fidelity Small Cap Index 0.68

Polar Capital Glb Healthcare Ord 0.60

iShares Russell 2000 Growth ETF 0.58

UTM IM GBP AXA Framlington Biotech 0.50

Principal SmallCap Growth I Instl 0.46

State St Russell Sm/Mid Cp® Indx SL Cl I 0.42

Emerald Growth A 0.39

iShares Biotechnology ETF 0.38

Fidelity Extended Market Index 0.35

Swedbank Robur Healthcare A 0.34

Vanguard Russell 2000 ETF 0.33

Schwab US Small-Cap ETF™ 0.32

F/m Emerald Life Sciences Innovation ETF 0.32

DWS ESG Biotech LC 0.30

MEDICAL BioHealth EUR Acc 0.28

SAVARA INC Market Status

Strong Buy: 4

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

SAVARA INC Fundamentals

Market Cap 1015.10 M

PB Ratio 5.0174

PE Ratio 0.0

Enterprise Value 813.41 M

Total Assets 253.44 M

Volume 9317313

SAVARA INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:257000 0.3M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:-136000 -0.1M, FY20:257000 0.3M, FY19:null 0.0M

Annual Net worth FY23:-48899000 -48.9M, FY22:-38946000 -38.9M, FY21:-45296000 -45.3M, FY20:-51097000 -51.1M, FY19:-105025000 -105.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-385000 -0.4M, Q1/2025:-905000 -0.9M, Q3/2024:null 0.0M, Q2/2024:-69000 -0.1M

Quarterly Net worth Q3/2025:-29561000 -29.6M, Q2/2025:-30401000 -30.4M, Q1/2025:-26639000 -26.6M, Q3/2024:-24248000 -24.2M, Q2/2024:-22243000 -22.2M

About SAVARA INC & investment objective

Company Information Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Organisation Biotechnology

Employees 70

Industry Biotechnology

CEO Mr. Matthew Pauls J.D., M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

SAVARA INC FAQs

What is the share price of SAVARA INC today?

The current share price of SAVARA INC is $5.02.

Can I buy SAVARA INC shares in India?

Yes, Indian investors can buy SAVARA INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy SAVARA INC shares in India?

You can easily invest in SAVARA INC shares from India by:

Can I buy fractional shares of SAVARA INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SAVARA INC?

SAVARA INC has a market cap of $1015.10 M.

In which sector does SAVARA INC belong?

SAVARA INC operates in the Biotechnology sector.

What documents are required to invest in SAVARA INC stocks?

To invest, you typically need:

What is the PE and PB ratio of SAVARA INC?

The PE ratio of SAVARA INC is N/A and the PB ratio is 5.02.